GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Price-to-Tangible-Book

Maat Pharma (XPAR:MAAT) Price-to-Tangible-Book : 4.82 (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma Price-to-Tangible-Book?

As of today (2024-06-07), Maat Pharma's share price is €7.96. Maat Pharma's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €1.65. Hence, Maat Pharma's Price to Tangible Book Ratio of today is 4.82.

The historical rank and industry rank for Maat Pharma's Price-to-Tangible-Book or its related term are showing as below:

XPAR:MAAT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.1   Med: 4.23   Max: 268.14
Current: 4.82

During the past 6 years, Maat Pharma's highest Price to Tangible Book Ratio was 268.14. The lowest was 3.10. And the median was 4.23.

XPAR:MAAT's Price-to-Tangible-Book is ranked worse than
70.36% of 1218 companies
in the Biotechnology industry
Industry Median: 2.79 vs XPAR:MAAT: 4.82

A closely related ratio is called PB Ratio. As of today, Maat Pharma's share price is €7.96. Maat Pharma's Book Value per Sharefor the quarter that ended in Dec. 2023 was €1.77. Hence, Maat Pharma's P/B Ratio of today is 4.51.


Maat Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Maat Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma Price-to-Tangible-Book Chart

Maat Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial - 9.89 3.38 3.10 4.23

Maat Pharma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.38 3.47 3.10 2.79 4.23

Competitive Comparison of Maat Pharma's Price-to-Tangible-Book

For the Biotechnology subindustry, Maat Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maat Pharma's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maat Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Maat Pharma's Price-to-Tangible-Book falls into.



Maat Pharma Price-to-Tangible-Book Calculation

Maat Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=7.96/1.65
=4.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Maat Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Maat Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Maat Pharma (XPAR:MAAT) Business Description

Traded in Other Exchanges
Address
70 Avenue Tony Garnier, Lyon, FRA, 69007
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma (XPAR:MAAT) Headlines

No Headlines